Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Can vimentin be an emerging ea...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Can vimentin be an emerging early detection molecular biomarker in oral squamous cell carcinoma?

Bibliographic Details
Published in:Oral Oncology Reports
Main Authors: Kalaiselvi Krishnamoorthy, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman
Format: Article
Language:English
Published: Elsevier 2024-06-01
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024002760
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2772906024002760

Similar Items

  • Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma
    by: Kalaiselvi Krishnamoorthy, et al.
    Published: (2024-06-01)
  • Nucleostemin and p-STAT3 as early diagnostic potential markers in oral squamous cell carcinoma
    by: Jayaraman Selvaraj, et al.
    Published: (2023-12-01)
  • Emerging therapeutic targets in oral squamous cell carcinoma: Insights from genetic alterations
    by: Santosh R. Patil, et al.
    Published: (2024-06-01)
  • Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3)
    by: Selvaraj Jayaraman, et al.
    Published: (2023-11-01)
  • CDK5RAP2: A potential prognostication biomarker for oral squamous cell carcinoma?
    by: Benson Paul, et al.
    Published: (2024-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs